Hematology Diagnostic DevicesVarious factors are working to fuel the growth of the global hematology diagnostics market, according to a recent Persistence Market Research (PMR) report. The use of hematology diagnostics has increased in recent years due to rising incidence of blood disorder diseases. This, in turn, has increased the demand for hematology analyzers and reagents that can provide accurate and timely results for efficient patient management.

There are various types of blood disorders such as platelet disorders, excessive clotting, and bleeding problems (hemostatis); anemia; leukemia and myeloma which are cancers of the blood, and eosinophilic disorders, which refer to problems with one white blood cell type. Modern hematology systems are state-of-the-art automated devices that analyze blood samples to determine the number of different types of red and white blood cells, blood platelets, hemoglobin, and hamatocrit levels.

According to the PMR report, hemostatis is the largest segment of the global hematology diagnostics market. The other key findings of the report are as follows:

  • The main factors driving the growth of the hematology diagnostics market are increasing aging population, increasing incidence of blood disorders, technological advancements, mounting demand for improved healthcare facilities and increased government initiatives to support healthcare infrastructure.
  • Market growth may be restrained by the high cost of diagnostics, poor healthcare insurance coverage for diagnostic procedures, and lack of lack of awareness among the public about hematology diagnostics.
  • North America dominates the global hematology market, driven by the availability of a large number of diagnostic centers and rising R&D investment.
  • North America is followed by Europe. Asia is expected to witness a high growth rate due to improving healthcare infrastructure, with China and India expected to see fast growth due to the availability of large patient pools. The growing demand for technologically-advanced diagnosis devices and increased purchasing power of consumers are also driving growth of the hematology diagnostics market in Asia.

The introduction of digital imaging systems in hematology laboratories and growing use of microfluidics technology in hematology analyzers are factors that could create opportunities for growth of the global hematology diagnostics market. The report identifies the key players in the market as Abbott Diagnostics, Hemocue, Horiba, Siemens Healthcare Diagnostics, Beckman Coulter, Bio-Rad Laboratories, Nihon Kohden Corporation, and Roche Diagnostics.